Tarsa Therapeutics, Inc.

Tarsa Therapeutics, Inc.

Osteoporosis

Tarsa Therapeutics developed an oral formulation of calcitonin, a naturally occurring hormone used by the body to regulate bone and cartilage. Calcitonin has had a long history of safety and efficacy as an osteoporosis therapy with expansion potential as a novel treatment for osteoarthritis.

Tarsa was acquired by R-Pharm US in 2018.